Bracco at ECR 2025: Innovations in Contrast Media and Sustainability

Bayer Submits MRI Contrast Agent Gadoquatrane for FDA Review

If approved, gadoquatrane would become the lowest-dose macrocyclic gadolinium-based contrast agent available in the U.S. market.

ECR2024: Bayer on its new Medical Imaging Core Lab Services

Bayer Launches Core Lab Services to Advance Imaging in Clinical Trials

Positive results from Phase III study for Bayer’s investigational contrast agent gadoquatrane

Bayer and Google Cloud ally to advance radiology AI development

Collaboration Aims to Accelerate Scalable AI Solutions in Medical Imaging and Combat Radiologist Burnout

AI-QUAL: First AI Module for Automated Prostate MRI Quality Scoring

Quibim launches AI-QUAL to standardize prostate MRI quality assessment and support more accurate prostate cancer diagnostics